UBS Group’s Liberty Capital Corp Series C GCI Group Common Stock GLIBK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.16M Sell
146,577
-3,702,858
-96% -$104M ﹤0.01% 4640
2026
Q1
$143M Buy
3,849,435
+615,827
+19% +$23.3M 0.02% 793
2025
Q4
$120M Buy
3,233,608
+1,162,370
+56% +$40.8M 0.02% 892
2025
Q3
$77.2M Buy
+2,071,238
New +$73.1M 0.01% 1247

Other funds holding GLIBK

UBS Group's GLIBK Position: Q2 2026 in Review

UBS Group reduced its Liberty Capital Corp Series C GCI Group Common Stock (GLIBK) stake by 96% in Q2 2026, selling an estimated $104M and leaving 146,577 shares worth $3.16M. The position accounts for ﹤0.01% of the portfolio, ranked #4640.

UBS Group first reported a position in GLIBK in Q3 2025 and has held it in 4 quarters since. The position peaked at $143M in Q1 2026. 210 funds tracked by Wall St. Rank hold GLIBK as of Q2 2026.

  • UBS Group held 146,577 shares of Liberty Capital Corp Series C GCI Group Common Stock worth $3.16M as of Q2 2026.
  • UBS Group sold 3,702,858 Liberty Capital Corp Series C GCI Group Common Stock shares in Q2 2026, an estimated $104M.
  • Liberty Capital Corp Series C GCI Group Common Stock made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #4640 holding.
  • UBS Group first reported a position in Liberty Capital Corp Series C GCI Group Common Stock in Q3 2025 and has held it in 4 quarters since.
  • UBS Group's Liberty Capital Corp Series C GCI Group Common Stock position peaked at $143M in Q1 2026.
  • 210 funds tracked by Wall St. Rank held Liberty Capital Corp Series C GCI Group Common Stock as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.